$7.18
Today
as of Aug 5, 16:50 ET
Last 30 days
Recent Press Releases & News
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
Kamada Signs $50 Million Plasma Supply Agreement With Biopharmaceutical Firm
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
Overview
52-week range
$6.50
$9.35
24% of range
Avg surprise (last 3)
+0.9%
Avg reaction (last 2)
-2.2%
50% positive
Latest IV / EM
63%
EM ±10.9% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $0.07 | $0.12 | -41.7% | 0.0% | -6.8% | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $0.13 | $0.09 | +44.4% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $0.07 | $0.07 | 0.0% | — | +2.3% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | $0.12 | $0.13 | -7.7% |